Advertisement
Review Article| Volume 47, ISSUE 1, P193-208, March 2018

Small Intestinal Bacterial Overgrowth

Nutritional Implications, Diagnosis, and Management
Published:December 06, 2017DOI:https://doi.org/10.1016/j.gtc.2017.09.008

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Gastroenterology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shah S.C.
        • Day L.W.
        • Somsouk M.
        • et al.
        Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.
        Aliment Pharmacol Ther. 2013; 38: 925-934
        • Abu-Shanab A.
        • Quigley E.M.
        Diagnosis of small intestinal bacterial overgrowth: the challenges persist!.
        Expert Rev Gastroenterol Hepatol. 2009; 3: 77-87
        • Bohm M.
        • Siwiec R.M.
        • Wo J.M.
        Diagnosis and management of small intestinal bacterial overgrowth.
        Nutr Clin Pract. 2013; 28: 289-299
        • Rautava S.
        Early microbial contact, the breast milk microbiome and child health.
        J Dev Orig Health Dis. 2016; 7: 5-14
        • Simrén M.
        • Barbara G.
        • Flint H.J.
        • et al.
        • and the Rome Foundation Committee
        Intestinal microbiota in functional bowel disorders: a Rome foundation report.
        Gut. 2013; 62: 159-176
        • Lane E.R.
        • Zisman T.L.
        • Suskind D.L.
        The microbiota in inflammatory bowel disease: current and therapeutic insights.
        J Inflamm Res. 2017; 10: 63-73
        • Miller L.S.
        • Vegesna A.K.
        • Sampath A.M.
        • et al.
        Ileocecal valve dysfunction in small intestinal bacterial overgrowth: a pilot study.
        World J Gastroenterol. 2012; 18: 6801-6808
        • Roland B.C.
        • Ciarleglio M.M.
        • Clarke J.O.
        • et al.
        Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO).
        Dig Dis Sci. 2014; 59: 1269-1277
        • Singleton A.O.
        • Redmond D.C.
        • McMurray J.E.
        Ileocecal resection and small bowel transit and absorption.
        Ann Surg. 1964; 159: 690-694
        • Fich A.
        • Steadman C.J.
        • Phillips S.F.
        • et al.
        Ileocolonic transit does not change after right hemicolectomy.
        Gastroenterology. 1992; 103: 794-799
        • Krajicek E.J.
        • Hansel S.L.
        Small intestinal bacterial overgrowth: a primary care review.
        Mayo Clin Proc. 2016; 91: 1828-1833
        • DiBaise J.K.
        • Young R.J.
        • Vanderhoof J.A.
        Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome.
        Clin Gastroenterol Hepatol. 2006; 4: 11-20
        • Seto C.
        • Jeraldo P.
        • Orenstein R.
        • et al.
        Prolonged use of proton pump inhibitors in healthy individuals reduces microbial diversity: implications for clostridium difficile susceptibility.
        Microbiome. 2014; 2 (eCollection 2014): 42
        • Husebye E.
        • Skar V.
        • Hoverstad T.
        • et al.
        Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people.
        Gut. 1992; 33: 1331-1337
        • Lo W.K.
        • Chan W.W.
        Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.
        Clin Gastroenterol Hepatol. 2013; 11: 483-490
        • Pignata C.
        • Budillon G.
        • Monaco G.
        • et al.
        Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes.
        Gut. 1990; 31: 879-882
        • Kruszewska D.
        • Ljungh A.
        • Hynes S.O.
        • et al.
        Effect of the antibacterial activity of pig pancreatic juice on human multiresistant bacteria.
        Pancreas. 2004; 28: 191-199
        • Van Felius I.D.
        • Akkermans L.M.
        • Bosscha K.
        • et al.
        Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis.
        Neurogastroenterol Motil. 2003; 15: 267-276
        • Kaufman S.S.
        • Loseke C.A.
        • Lupo J.V.
        • et al.
        Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome.
        J Pediatr. 1997; 131: 356-361
        • Kim Y.S.
        • Spritz N.
        • Blum M.
        • et al.
        The role of altered bile acid metabolism in the steatorrhea of experimental blind loop.
        J Clin Invest. 1966; 45: 956-962
        • Sherman P.
        • Wesley A.
        • Forstner G.
        Sequential disaccharidase loss in rat intestinal blind loops: impact of malnutrition.
        Am J Physiol. 1985; 248: G626-G632
        • Jones E.A.
        • Craigie A.
        • Tavill A.S.
        • et al.
        Protein metabolism in the intestinal stagnant loop syndrome.
        Gut. 1968; 9: 466-469
        • Jain A.
        • Reif S.
        • O'Neil K.
        • et al.
        Small intestinal bacterial overgrowth and protein-losing enteropathy in an infant with AIDS.
        J Pediatr Gastroenterol Nutr. 1992; 15: 452-454
        • Su J.
        • Smith M.B.
        • Rerknimitr R.
        • et al.
        Small intestine bacterial overgrowth presenting as protein-losing enteropathy.
        Dig Dis Sci. 1998; 43: 679-681
        • Hasan M.
        • Finucane P.
        Intestinal malabsorption presenting with night blindness.
        Br J Clin Pract. 1993; 47: 275-276
        • Stotzer P.O.
        • Johansson C.
        • Mellström D.
        • et al.
        Bone mineral density in patients with small intestinal bacterial overgrowth.
        Hepatogastroenterology. 2003; 50: 1415-1418
        • Brin M.F.
        • Fetell M.R.
        • Green P.H.
        • et al.
        Blind loop syndrome, vitamin E malabsorption, and spinocerebellar degeneration.
        Neurology. 1985; 35: 338-342
        • Welkos S.L.
        • Toskes P.P.
        • Baer H.
        Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome.
        Gastroenterology. 1981; 80: 313-320
        • Sachdev A.H.
        • Pimentel M.
        Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.
        Ther Adv Chronic Dis. 2013; 4: 223-231
        • Stotzer P.O.
        • Björnsson E.S.
        • Abrahamsson H.
        Interdigestive and postprandial motility in small-intestinal bacterial overgrowth.
        Scand J Gastroenterol. 1996; 31: 875-880
        • Kunkel D.
        • Basseri R.J.
        • Makhani M.D.
        • et al.
        Methane on breath testing is associated with constipation: a systematic review and meta-analysis.
        Dig Dis Sci. 2011; 56: 1612-1618
        • Rezaie A.
        • Pimentel M.
        • Rao S.S.
        How to test and treat small intestinal bacterial overgrowth: an evidence-based approach.
        Curr Gastroenterol Rep. 2016; 18: 8
        • Khoshini R.
        • Dai S.C.
        • Lezcano S.
        • et al.
        A systematic review of diagnostic tests for small intestinal bacterial overgrowth.
        Dig Dis Sci. 2008; 53: 1443-1454
        • Saad R.J.
        • Chey W.D.
        Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.
        Clin Gastroenterol Hepato. 2014; 12: 1964-1972
        • Tillman R.
        • King C.
        • Toskes P.
        Continued experience with the xylose breath test: evidence that the small bowel culture as the gold standard for bacterial overgrowth may be tarnished.
        Gastroenterology. 1981; 80: 1304
        • Corazza G.R.
        • Menozzi M.G.
        • Strocchi A.
        • et al.
        The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing.
        Gastroenterology. 1990; 98: 302-309
        • Donaldson Jr., R.M.
        Normal bacterial populations of the intestine and their relation to intestinal function.
        N Engl J Med. 1964; 270: 938-945
        • Rezaie A.
        • Buresi M.
        • Lembo A.
        • et al.
        Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus.
        Am J Gastroenterol. 2017; 112: 775-784
        • Poserud I.
        • Stotzer P.O.
        • Björnsson E.S.
        • et al.
        Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
        Gut. 2007; 56: 802-808
        • Erdogan A.
        • Rao S.S.
        • Gulley D.
        • et al.
        Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test.
        Neurogastroenterol Motil. 2015; 27: 481-489
        • Pyleris E.
        • Giamarellos-Bourboulis E.J.
        • Tzivras D.
        • et al.
        The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.
        Dig Dis Sci. 2012; 57: 1321-1329
        • Gasbarrini A.
        • Corazza G.R.
        • Gasbarrini G.
        • et al.
        Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.
        Aliment Pharmacol Ther. 2009; 29: 1-49
        • Quigley E.M.
        Small intestinal bacterial overgrowth: what it is and what it is not.
        Curr Opin Gastroenterol. 2014; 30: 141-146
        • Sellin J.H.
        • Hart R.
        Glucose malabsorption associated with rapid intestinal transit.
        Am J Gastroenterol. 1992; 87: 584-589
        • Lin E.C.
        • Massey B.T.
        Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth.
        Clin Gastroenterol Hepatol. 2016; 14: 203-208
        • Pimentel M.
        Breath testing for small intestinal bacterial overgrowth: should we bother?.
        Am J Gastroenterol. 2016; 111: 307-308
        • Yu D.
        • Cheeseman F.
        • Vanner S.
        Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.
        Gut. 2011; 60: 334-340
        • Walters B.
        • Vanner S.J.
        Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls.
        Am J Gastroenterol. 2005; 100: 1566-1570
        • Riordan S.M.
        • McIver C.J.
        • Walker B.M.
        • et al.
        The lactulose breath hydrogen test and small intestinal bacterial overgrowth.
        Am J Gastroenterol. 1996; 91: 1795-1803
        • Triantafyllou K.
        • Pimentel M.
        Understanding breath tests for small intestinal bacterial overgrowth.
        Clin Gastroenterol Hepatol. 2016; 14: 1362-1363
        • Massey B.T.
        • Lin E.C.
        Reply.
        Clin Gastroenterol Hepatol. 2016; 14: 1363-1364
        • Zhao J.
        • Zheng X.
        • Chu H.
        • et al.
        A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
        Neurogastroenterol Motil. 2014; 26: 794-802
        • Pimentel M.
        • Chow E.J.
        • Lin H.C.
        Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
        Am J Gastroenterol. 2000; 95: 3503-3506
        • Hirakawa M.
        • Iida M.
        • Kohrogi N.
        • et al.
        Hydrogen breath test assessment of orocecal transit time: comparison with barium meal study.
        Am J Gastroenterol. 1988; 83: 1361-1363
        • Madrid A.M.
        • Hurtado C.
        • Venegas M.
        • et al.
        Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
        Am J Gastroenterol. 2001; 96: 1251-1255
        • Pimentel M.
        • Morales W.
        • Lezcano S.
        • et al.
        Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.
        Gastroenterol Hepatol (N Y). 2009; 5: 435-442
        • Soudah H.C.
        • Hasler W.L.
        • Owyang C.
        Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
        N Engl J Med. 1991; 325: 1461-1467
        • Pimentel M.
        • Constantino T.
        • Kong Y.
        • et al.
        A 14-day elemental diet is highly effective in normalizing the lactulose breath test.
        Dig Dis Sci. 2004; 49: 73-77
        • Rosania R.
        • Giorgio F.
        • Principi M.
        • et al.
        Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation.
        Curr Clin Pharmacol. 2013; 8: 169-172
        • Khalighi A.R.
        • Khalighi M.R.
        • Behdani R.
        • et al.
        Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)–a pilot study.
        Indian J Med Res. 2014; 140: 604-608
        • Bouhnik Y.
        • Alain S.
        • Attar A.
        • et al.
        Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome.
        Am J Gastroenterol. 1999; 94: 1327-1331
        • Gatta L.
        • Scarpignato C.
        Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth.
        Aliment Pharmacol Ther. 2017; 5: 604-616
        • Lauritano E.C.
        • Gabrielli M.
        • Scarpellini E.
        • et al.
        Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
        Am J Gastroenterol. 2008; 103: 2031-2035
        • Low K.
        • Hwang L.
        • Hua J.
        • et al.
        A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test.
        J Clin Gastroenterol. 2010; 44: 547-550
        • Pimentel M.
        • Chang C.
        • Chua K.S.
        • et al.
        Antibiotic treatment of constipation-predominant irritable bowel syndrome.
        Dig Dis Sci. 2014; 59: 1278-1285
        • Gottlieb K.
        • Wacher V.
        • Sliman J.
        • et al.
        Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders.
        Aliment Pharmacol Ther. 2016; 43: 197-212
        • Muskal S.M.
        • Sliman J.
        • Kokai-Kun J.
        • et al.
        Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway. Version 3.
        F1000Res. 2016; 5: 606
        • Giamarellos-Bourboulis E.
        • Tang J.
        • Pyleris E.
        • et al.
        Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.
        Scand J Gastroenterol. 2015; 50: 1076-1087